[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
JAMA Clinical Evidence Synopsis
June 4, 2014

Prophylactic Antibiotic Therapy in Chronic Obstructive Pulmonary Disease

Author Affiliations
  • 1Day Unit, Department of Respiratory Medicine, Montreal Chest Institute, Montreal, Quebec, Canada
  • 2Department of Medicine, The University of Auckland, Auckland, New Zealand
JAMA. 2014;311(21):2225-2226. doi:10.1001/jama.2014.4929
Abstract

Clinical Question  Is prophylactic antibiotic treatment associated with fewer exacerbations or improved health-related quality of life (HRQOL) in patients with chronic obstructive pulmonary disease (COPD)?

Bottom Line  Continuous macrolide antibiotic use for prophylaxis was associated with a clinically significant reduction in COPD exacerbations. Pulsed antibiotic use was not associated with benefit. Continuous and pulsed antibiotics were associated with improved HRQOL, but this was not clinically significant.

×